Literature DB >> 22731807

Neuropsychologists' beliefs about alcohol and dementia.

Jing Ee Tan1, Beth A Springate, Geoffrey Tremont.   

Abstract

Alcohol-related dementia (ARD) is a controversial concept, and the prevailing view of neuropsychologists regarding this disorder is unknown. The purpose of this study was to gain an understanding of neuropsychologists' beliefs and practices regarding ARD. A total of 140 board-certified neuropsychologists completed an anonymous online survey about alcohol and dementia. Almost all respondents (93%) reported alcohol has direct neurotoxic effects, but most were unsure whether moderate alcohol use can be neuroprotective. The presence and course of cognitive deficits as well as functional impairments were rated as the most important factors to consider when making this diagnosis, and declines in memory, executive functions, and processing speed were most frequently observed cognitive changes. Neuropsychologists were mixed in their opinions about cognitive prognosis, with half the sample endorsing stability of cognitive deficits and about one-third of the group indicating gradual improvement. Although laboratory workup was not a major diagnostic consideration, 68% of respondents recommended treatment with vitamins and nutritional supplements. Findings are consistent with the research literature and suggest that while neuropsychologists generally believe alcohol can have direct neurotoxic effects, they vary in their beliefs about diagnosis, treatment, and prognosis. Future research should focus on providing diagnostic and treatment guidelines for ARD.

Entities:  

Mesh:

Year:  2012        PMID: 22731807     DOI: 10.1080/13854046.2012.699102

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  1 in total

1.  Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: the HUNT study, Norway.

Authors:  Ellen Melbye Langballe; Helga Ask; Jostein Holmen; Eystein Stordal; Ingvild Saltvedt; Geir Selbæk; Arvid Fikseaunet; Sverre Bergh; Per Nafstad; Kristian Tambs
Journal:  Eur J Epidemiol       Date:  2015-05-13       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.